Myopia Progression: Clinical Trials

4 trials for Myopia Progression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Active not recruiting 1, Completed 1

Follow Myopia Progression: new trials by email Literature Review of Myopia Progression trials Research Report on Myopia Progression

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
MiSight Contact Lenses (CooperVision), Albiliti 1-Day (Johnson and Johnson, VisionCare) - Myopia Progression
Phase 3Active not recruitingAston University662026-03-212026-09-04
Atropine in the Treatment of Myopia Study in Malaysia
Low dose atropine sulfate eye drops, Placebo - Myopia Progression
Phase 3RecruitingIDB VisionCare SDN BHD1442025-09-172026-01-09
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops - Myopia, Myopia Progression
Phase 3RecruitingOupushifang Pharmaceutical Technology Co., Ltd.6062024-06-152024-12-24
Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression
Atropine sulphate eye drop 0.01%, Atropine sulphate eye drop 0.03%, Atropine sulphate eye drop 0.05% - Myopia Progression, Atropine
Phase 3CompletedKhyber Medical College, Peshawar952024-06-032026-06-10

Narrower conditions

Myopia (2)  ·  Myopia, Degenerative (1)

Broader conditions

Eye Diseases (2)  ·  Refractive Errors (2)

Sponsors

Aston University (1)  ·  IDB VisionCare SDN BHD (1)  ·  Khyber Medical College, Peshawar (1)  ·  Oupushifang Pharmaceutical Technology Co., Ltd. (1)

Countries

China (1)  ·  Malaysia (1)  ·  New Zealand (1)  ·  Pakistan (1)

Top investigators

Nazli Gul, FCPS (1)  ·  Ningli Wang, Postdoctoral (1)